# A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

> **NCT03560882** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Joaquina Baranda** · enrollment: 50 (estimated)

## Conditions studied

- Malignant Disease
- Solid Tumor
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Cancer
- Relapsed Hematologic Malignancy

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT03560882
- **Lead sponsor:** Joaquina Baranda
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-07-19
- **Primary completion:** 2022-10-14
- **Final completion:** 2026-08-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03560882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03560882, "A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT03560882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*